+ All Categories
Home > Health & Medicine > HealthEd and Amylin EXL Digital Pharma West 2011

HealthEd and Amylin EXL Digital Pharma West 2011

Date post: 20-Oct-2014
Category:
View: 3,584 times
Download: 1 times
Share this document with a friend
Description:
"Return On Education" presentation by HealthEd and Amylin Pharmaceuticals, EXL Digital Pharma West 2011, San Francisco. Presenters: Susan Eno Collins and Susan M. LaRue
Popular Tags:
40
Return on Education—Leveraging Patient Education to Improve Treatment Outcomes Susan LaRue, RD,CDE, Clinical Education Specialist, Medical Relations and Information, Amylin Pharmaceuticals, Inc Susan Eno Collins, RD, CHES, SVP, Health Education, HealthEd; Community Leader, SurroundHealth.net
Transcript
Page 1: HealthEd and Amylin EXL Digital Pharma West 2011

Return on Education™—Leveraging Patient Education to Improve Treatment Outcomes

Susan LaRue, RD,CDE, Clinical Education Specialist, Medical Relations and Information, Amylin Pharmaceuticals, Inc

Susan Eno Collins, RD, CHES, SVP, Health Education, HealthEd; Community Leader, SurroundHealth.net

Page 2: HealthEd and Amylin EXL Digital Pharma West 2011

04/07/2023 2

Give us the next 30 minutes and we will… Give you an introduction to Return on Education™—a framework you

can use to develop effective programs

Show you a case study where we incorporated the framework

Share the positive results we got

Hopefully, answer your questions

Page 3: HealthEd and Amylin EXL Digital Pharma West 2011

Return on EducationTM: Starts with a behavior-based approach for developing programs

3

Develop Objectives

Uncover Insights

Choose Behavior Model

ProgramDevelopment

and Refinement

During (In Development)Post (After Program Launch)Pre (In Planning)

LaunchCapture and Analyze Results

Page 4: HealthEd and Amylin EXL Digital Pharma West 2011

04/07/2023 4

Desired Action

And includes a Return on EducationTM framework for evaluating the outcomes of the program

Customized based on program objectives

Examples include

‒ Screening/diagnosis

‒ Talking with HCP

‒ Fill initial Rx

‒ Take Rx as prescribed

‒ Conversion

‒ Use of device

Program

‒Engagement

‒Reach

‒Frequency

Symptom alleviation

HEDIS measurement

Function

Clinical measures

Business

‒Length on therapy

‒ Increased sales

‒Rep access

Program/Business Impact

Health Outcomes

Education Impact

Persuasion

(“This is important to me”)

+

Clarity

(“I understand and can apply what I am learning”)

+

Insight-driven content

(“This relates to me and my life”)

+

Reaction to tactic/program

(“This has been worth it. I have learned something new.”)

Page 5: HealthEd and Amylin EXL Digital Pharma West 2011

Case study: Effects of Patient Education Support Program on Pramlintide Adherence

Page 6: HealthEd and Amylin EXL Digital Pharma West 2011

04/07/2023 6

Acknowledgement

• This case study is based on the following publication:• Lorenzi GM, LaRue SM, Collins SE. Effects of a patient support program on

pramlintide adherence. Clin Diabetes. 2011;29(1):17-24.

• We wish to thank the lead author, Gayle Lorenzi, RN, CDE, University of California at San Diego, for her expertise and contributions

Page 7: HealthEd and Amylin EXL Digital Pharma West 2011

04/07/2023 7

Pramlintide is taken as an adjunct to mealtime insulin Analog of the hormone amylin

‒ Hormone cosecreted with insulin by the beta cells in the pancreas

‒ Deficient in people with type 2 and type 1 diabetes

Adjunct treatment for people with type 2 or type 1 diabetes who take mealtime insulin

Injectable

Taken prior to major meals

‒ A major meal is >30 grams of carbohydrate or > 250 calories

Offers improved blood glucose control

‒ Fewer blood sugar swings throughout the day

‒ Added benefit of potential weight loss

Page 8: HealthEd and Amylin EXL Digital Pharma West 2011

04/07/2023 8

The numbers shed light on the product’s challenges 3

‒ Patients taking pramlintide at meal times may already be taking 4 shots of insulin a day

‒ Pramlintide becomes 3 additional shots to integrate into a daily routine

50%1

‒ Adherence to medicines across multiple chronic conditions, including diabetes

50% in 2 months2

‒ About 50% of patients starting pramlintide discontinued therapy within 2 months

Sources: 1. World Health Organization: Adherence to long-term therapies: evidence for action. Geneva, World Health Organization, 2003. 2. Data on file. San Diego, CA., Amylin Pharmaceuticals, Inc.

Page 9: HealthEd and Amylin EXL Digital Pharma West 2011

04/07/2023 9

Why did patients stop treatment? Their answers revealed a need

Did not lose weight

Additional injections requiredSide effects (volunteered)

Too expensive

Dosing regimen too complicated

Lack of effectiveness (volunteered)

Source: Adapted from Lorenzi GM, LaRue SM, Collins SE. Effects of a patient support program on pramlintide adherence. Clin Diabetes. 2011;29(1):17-24.

Potentially 57% of reasons for discontinuation can be addressed withadditional education/realistic expectations

28%

20%15%

13%

9% 5%

Main Reason for Discontinuing PramlintidePercent of Patients

(N=127)

Page 10: HealthEd and Amylin EXL Digital Pharma West 2011

To develop our program, we started with the Return on EducationTM approach

10

Develop Objectives

Uncover Insights

Choose Behavior Model

ProgramDevelopment

and Refinement

During (In Development)Post (After Program Launch)Pre (In Planning)

LaunchCapture and Analyze Results

Page 11: HealthEd and Amylin EXL Digital Pharma West 2011

04/07/2023 11

Program objectives were based on behavior-change principles

Set realistic expectations at the beginning of treatment

Build problem-solving and communication skills

Increase sense of self-efficacy (“I can do this”)

Page 12: HealthEd and Amylin EXL Digital Pharma West 2011

04/07/2023 12

Trying to take a walk in patients’ shoes (uncovering insights)

Moti

vato

rs

•Healthcare provider knowledge

•Realistic expectations•Hope for improvement•Adjustment period/need for flexibility

•Insulin/appetite changes•Weight loss

Starting Pramlintide Therapy

Moti

vato

rs

•Improved glucose levels, fewer fluctuations

•Improved AIC•Perceived benefits of therapy

•Increased sense of control of diabetes

•Weight loss•Less insulin

Maintaining Pramlintide Therapy

Barr

iers

•Additional injections•Side effects•Therapy disappointment•Impact of changes on family dynamics

•Suboptimal dosing; fewer benefits realized

•Life demands

Barr

iers

•Lack of healthcare provider support and education

•Frustration: different routine and considerations

•Unanticipated hyperglycemia

•Injection burden and treatment complexity

•Unexpected side effects

Page 13: HealthEd and Amylin EXL Digital Pharma West 2011

04/07/2023 13

Behavior models provide a blueprint for program design

Hunch and Intuition

Feels right Seems cool This type of program

worked before Have seen other programs

designed like this

Program designed using Social Cognitive Theory

Evidence-Based Approach

Design based on understanding of behavior

Models suggest how to create program to have an impact

Create unique, tailored solutions to problems

Page 14: HealthEd and Amylin EXL Digital Pharma West 2011

04/07/2023 14

Designed for clarity by integrating health literacy principles

“One out of 3 Americans have basic or below basic health literacy skills”

Source: National Center for Education Statistics.  The Health Literacy of America’s Adults: Results from the 2003 National Assessment of Adult Literacy. (NCES 2006-483). http://nces.ed.gov/pubsearch/pubsinfo.asp?pubid=2006483.

“I have challenges accessing, understanding, and using

health information “

Page 15: HealthEd and Amylin EXL Digital Pharma West 2011

Applying the Return on EducationTM approach to develop the program

15

Develop Objectives

Uncover Insights

Choose Behavior Model

Post (After Program Launch)Pre (In Planning)

LaunchCapture and Analyze Results

ProgramDevelopment

and Refinement

During (In Development)

Page 16: HealthEd and Amylin EXL Digital Pharma West 2011

04/07/2023 16

Maintaining Pramlintide Therapy

Newsletters

Co-pay card

Share Your StoryFeedback survey

24/7 Information and education

Outbound/Inbound calls with nurses

Starting Pramlintide Therapy

In-officestarter kit with

demo video

Newsletter with expert and patient interviews

Welcome kit with goal setting and wellness map

Co-pay card24/7 Information

and educationOutbound/inbound

calls with nurses

Program design was mapped to insights…

Moti

vato

rs

•Healthcare provider knowledge

•Realistic expectations•Hope for improvement•Adjustment period/need for flexibility

•Insulin/appetite changes•Weight loss

Starting Pramlintide Therapy

Moti

vato

rs

•Improved glucose levels, fewer fluctuations

•Improved AIC•Perceived benefits of therapy

•Increased sense of control of diabetes

•Weight loss•Less insulin

Maintaining Pramlintide Therapy

Barr

iers

•Additional injections•Side effects•Therapy disappointment•Impact of changes on family dynamics

•Suboptimal dosing; fewer benefits realized

•Life demands

Barr

iers

•Lack of health care provider support and education

•Frustration: different routine and considerations

•Unanticipated hyperglycemia

•Injection burden and treatment complexity

•Unexpected side effects

Page 17: HealthEd and Amylin EXL Digital Pharma West 2011

04/07/2023 17

To create a holistic, integrated experience Maintaining

Pramlintide Therapy

Newsletters

Co-pay card

Share Your StoryFeedback survey

24/7 Information and education

Outbound/Inbound calls with nurses

Starting Pramlintide Therapy

In-officestarter kit with

demo video

Newsletter with expert and patient interviews

Welcome kit with goal setting and wellness map

Co-pay card24/7 Information

and educationOutbound/inbound

calls with nurses

Page 18: HealthEd and Amylin EXL Digital Pharma West 2011

Outcomes of a Behaviorally Based Program

Page 19: HealthEd and Amylin EXL Digital Pharma West 2011

Did the Return on EducationTM approach work?

19

Develop Objectives

Uncover Insights

Choose Behavior Model

ProgramDevelopment

and Refinement

During (In Development)Pre (In Planning)

LaunchCapture and Analyze Results

Post (After Program Launch)

Page 20: HealthEd and Amylin EXL Digital Pharma West 2011

04/07/2023 20

Education Impact

Persuasion

Behavior Change Model Metrics

Change in Knowledge

Change in Attitudes

Change in Skills

+Clarity

Clear by Design

+Insight-driven content

Tone

Relevance

Accuracy of Information

+Reaction to tactic/program

Satisfaction

Appeal

Usefulness

Needs Met

Impact

Intended/Actual use of materials

Return on EducationTM framework guided the evaluation plan

Customized based on program objectives

Examples include

‒ Screening/diagnosis

‒ Talking with HCP

‒ Fill initial Rx

‒ Take Rx as prescribed

‒ Conversion

‒ Use of device

Desired Action

Program

‒ Engagement

‒ Reach

‒ Frequency

‒ Enrollment

‒ Channel preference

‒ Site visits

Symptom alleviation

HEDIS measurement

Function

Clinical measures

Business

‒ Length on therapy

‒ Increased sales

‒ Rep access

‒ Market expansion

Program/Business Impact

Health Outcomes

Page 21: HealthEd and Amylin EXL Digital Pharma West 2011

04/07/2023 21

Program was relevant

Q: Would you like to have more, less or about the same: Information about organizing my medicines

About the Same

Less More No Response

44%

11%

31%

14%

75%: same or more vs. 11% less

75% of respondents want the same or more level of information about organizing their medicines

Source: Data on file. San Diego, CA., Amylin Pharmaceuticals, Inc.

Page 22: HealthEd and Amylin EXL Digital Pharma West 2011

Program had high appeal

Q: Would you like to have more, less or about the same: Tools for talking with my HCP

About the Same

Less More No Answer

47%

13%

24%

16%

71%: same or more vs. 13% less

71% of respondents want the same or more tools for talking with their HCP

Source: Data on file. San Diego, CA, Amylin Pharmaceuticals, Inc.

Page 23: HealthEd and Amylin EXL Digital Pharma West 2011

04/07/2023 23

Series10

10

20

30

40

50

60

70

80

90

65% 67%70%

79%

67% 65%

80% 81%

Survey 1 (N=358)

Program was usefulPe

rcen

tage

of P

atien

ts

Patients Wanted:

The same/more frequent diabetes information

The same/more frequentnewsletters

The same/longer duration of calls

The same/more frequent contact

Source: Adapted from Lorenzi GM, LaRue SM, Collins SE. Effects of a patient support program on pramlintide adherence. Clin Diabetes. 2011;29(1):17-24.

Page 24: HealthEd and Amylin EXL Digital Pharma West 2011

24

Prompted patients to talk with their HCPs

Q: The Support Program has helped me talk with my HCP about my pramlintide treatment

Agree Disagree Neither agree nor disagree

No Answer

51%

6%

39%

4%

Most respondents agree that the program helps them talk with their HCPs

Source: Data on file. San Diego, CA, Amylin Pharmaceuticals, Inc.

Page 25: HealthEd and Amylin EXL Digital Pharma West 2011

04/07/2023 25

Series10

20

40

60

80

10088%

84%80%

94%89%

85%

Survey 1 (N=358)

Perc

enta

ge o

f Pati

ents

Patients Reported:

High self-reported compliance and persistency

On and continuing therapy the first 3 months

Dosing 2 or 3 times daily

Administration of maintenance dose

Source: Adapted from Lorenzi GM, LaRue SM, Collins SE. Effects of a patient support program on pramlintide adherence. Clin Diabetes. 2011;29(1):17-24.

Page 26: HealthEd and Amylin EXL Digital Pharma West 2011

04/07/2023 26

Improvements were demonstrated

Patients in program were on pramlintide 50% longer relative to those not in program

Source: Adapted from Lorenzi GM, LaRue SM, Collins SE. Effects of a patient support program on pramlintide adherence. Clin Diabetes. 2011;29(1):17-24.

Page 27: HealthEd and Amylin EXL Digital Pharma West 2011

Program refinement based on analysis

Page 28: HealthEd and Amylin EXL Digital Pharma West 2011

Using the Return on EducationTM approach to refine

©2011 HealthEd Group, Inc. 28

Develop Objectives

Uncover Insights

Choose Behavior Model

ProgramDevelopment

and Refinement

During (In Development)Pre (In Planning)Post (After Program Launch)

LaunchCapture and Analyze Results

Page 29: HealthEd and Amylin EXL Digital Pharma West 2011

04/07/2023 29

Teachable moments shouldn’t be missed Web enrollments make up 50% of enrollees and often occur outside of

business hours of call center.

Video on BRAND.com creates continuity and familiarity

Video-based FAQs feature call center nurse

Page 30: HealthEd and Amylin EXL Digital Pharma West 2011

04/07/2023 30

Educational game developed to address confusion about Major Meals

Brand.

BrandBrand

Page 31: HealthEd and Amylin EXL Digital Pharma West 2011

04/07/2023 31

One barrier and motivator still had to be addressed

Moti

vato

rs

•Healthcare provider knowledge

•Realistic expectations•Hope for improvement•Adjustment period/need for flexibility

•Insulin/appetite changes•Weight loss

Starting Pramlintide Therapy

Barr

iers

•Lack of healthcare provider support and education

•Frustration: different routine and considerations

•Unanticipated hyperglycemia

•Injection burden and treatment complexity

•Unexpected side effects

Page 32: HealthEd and Amylin EXL Digital Pharma West 2011

A challenge and opportunity for you

Page 33: HealthEd and Amylin EXL Digital Pharma West 2011

You can use the Return on EducationTM approach to createa solution that promotes action and change

33

Develop Objectives

Uncover Insights

Choose Behavior Model

ProgramDevelopment

andRefinement

During (In Development)Post (After Program Launch)Pre (In Planning)

LaunchCapture and Analyze Results

Page 34: HealthEd and Amylin EXL Digital Pharma West 2011

04/07/2023 34

Desired Action

And evaluate your Return on EducationTM

Customized based on program objectives

Examples include

‒ Screening/diagnosis

‒ Talking with HCP

‒ Fill initial Rx

‒ Take Rx as prescribed

‒ Conversion

‒ Use of device

Program

‒Engagement

‒Reach

‒Frequency

Symptom alleviation

HEDIS measurement

Function

Clinical measures

Business

‒Length on therapy

‒ Increased sales

‒Rep access

Program/Business Impact

Health Outcomes

Education Impact

Persuasion

+

Clarity

+

Insight-driven content

+

Reaction to tactic/program

Page 35: HealthEd and Amylin EXL Digital Pharma West 2011

04/07/2023 35

This is a complicated recipe

Page 36: HealthEd and Amylin EXL Digital Pharma West 2011

04/07/2023 36

What patients have to manage day to day can also be complicated

“My Day”

Page 37: HealthEd and Amylin EXL Digital Pharma West 2011

37

Discussion

Hands On

Audiovisual

Seeing

HearRead

Digital solutions can help make learning more effective

Within just a few minutes of leaving the doctor’s office, patients may remember less than 50% of the critical information the doctor shared.2

HCP Office Visit

90%

60%-70%

40%-50%

10%-20%

5%-15%

Retention ratesof different learning

styles1

1. Adapted from Edgar Dale’s “Cone of Experience.

2. Davis TC, Williams MV, Marin E, Parker RM, Glass J. Health literacy and cancer communication. CA Cancer J Clin. 2002;52:134-149.

Page 38: HealthEd and Amylin EXL Digital Pharma West 2011

04/07/2023 38

Which can lead to positive health outcomes

“My Health”

Page 39: HealthEd and Amylin EXL Digital Pharma West 2011

THANK YOU! Time for your questions

04/07/2023

Page 40: HealthEd and Amylin EXL Digital Pharma West 2011

04/07/2023 40

To contact us Susan LaRue [email protected]

Susan Eno Collins [email protected]

To obtain a copy of this presentation, go to www.healthed.com


Recommended